Alector (ALEC) Accounts Payables (2018 - 2026)
Alector (ALEC) posted quarterly Accounts Payables of $1.4 million for Q1 2026, down 38.82% year-over-year from $2.3 million in Q1 2025, and down 15.85% quarter-over-quarter from $1.7 million in Q4 2025.
Alector (ALEC) Accounts Payables (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Accounts Payables for 9 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 38.82% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 38.82% YoY), while the FY2025 annual figure was $1.7 million, down 23.66% from the prior year.
- Accounts Payables slipped to $1.4 million in Q1 2026 per ALEC's latest filing, from $1.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $6.8 million in Q1 2022 and bottomed at $1.4 million in Q1 2026.
- Historically, Accounts Payables has averaged $3.8 million across 5 years, with a median of $4.4 million in 2024.
- On a YoY basis, Accounts Payables climbed as much as 94.19% in 2022 and fell as far as 61.1% in 2022.
- Alector's Accounts Payables stood at $4.2 million in 2022, then dropped by 9.88% to $3.8 million in 2023, then slumped by 41.32% to $2.2 million in 2024, then slipped by 23.66% to $1.7 million in 2025, then dropped by 15.85% to $1.4 million in 2026.
- Business Quant data shows ALEC's Accounts Payables at $1.4 million in Q1 2026, $1.7 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 2.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 4.76 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 4.68 Mn |
| Jun 30, 2023 | 4.67 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Sep 30, 2022 | 4.55 Mn |
| Jun 30, 2022 | 4.65 Mn |
| Mar 31, 2022 | 6.75 Mn |
| Dec 31, 2021 | 4.75 Mn |
| Sep 30, 2021 | 2.34 Mn |